<DOC>
	<DOCNO>NCT02220257</DOCNO>
	<brief_summary>Natural course diabetes mellitus involves gradual reduction β cell mass within islet Langerhans pancreas . Symptoms diabetes present mass insulin-producing cell reach point insulin concentration suffice maintain proper glycaemia . In many patient β cell regenerate shortly diagnosis diabetes initiation insulin therapy . This phenomenon call remission . The aim study asses influence occurrence duration remission development chronic complication diabetes patient outcome .</brief_summary>
	<brief_title>The Influence Partial Remission Phase Type 1 Diabetes Patient Outcome</brief_title>
	<detailed_description>Natural course diabetes mellitus involves gradual reduction β cell mass within islet Langerhans pancreas . Symptoms diabetes present mass insulin-producing cell reach point insulin concentration suffice maintain proper glycaemia . In many patient β cell regenerate shortly diagnosis diabetes initiation insulin therapy . This phenomenon call remission . The aim study asses influence occurrence duration remission development chronic complication diabetes patient outcome . Clinical remission define time follow criterion meet : HbA1c 6.5 % , dose exogenous insulin 0.3 U / kg body weight serum C-peptide concentration 0.5 ng / ml . Patients divide remission time follow-up ( remitters ) non-remitters . At follow-up occurrence chronic microvascular complication diabetes ( retinopathy , diabetic kidney disease neuropathy ) evaluate .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . Newly diagnose type 1 diabetes accord ADA ( American Diabetes Association ) 1997 criterion . 2 . Age 1835 year 3 . Education regard intensive functional insulin therapy time diagnosis 4 . Patient consent participation study 1 . Acute inflammation ( serum Creactive protein concentration ( hsCRP ) &gt; 10mg/L , leukocytosis &gt; 15x109/L , erythrocyte sedimentation rate ( OB ) &gt; 30 mm/h ) 2 . Laboratory sign liver damage : alanine aspartate aminotransferase elevate 2fold upper limit normal range 3 . History chronic disease ( e.g . asthma , neoplastic disease , liver cirrhosis ) 4 . Other autoimmunological disease diabetes 5 . Not confirm type 1 diabetes obtain result autoantibody</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>diabetes mellitus type 1</keyword>
	<keyword>remission , honeymoon</keyword>
	<keyword>microangiopathy</keyword>
</DOC>